scispace - formally typeset
S

Stephen Gwilym

Researcher at University of Oxford

Publications -  77
Citations -  2642

Stephen Gwilym is an academic researcher from University of Oxford. The author has contributed to research in topics: Medicine & Osteoarthritis. The author has an hindex of 19, co-authored 65 publications receiving 2111 citations. Previous affiliations of Stephen Gwilym include John Radcliffe Hospital & Nuffield Orthopaedic Centre.

Papers
More filters
Journal ArticleDOI

Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients.

TL;DR: Increased activity with the periaqueductal grey matter associated with stimulation of the skin in referred pain areas of patients with hip OA offers a central target for analgesia aimed at improving the treatment of this largely peripheral disease.
Journal ArticleDOI

Thalamic Atrophy Associated With Painful Osteoarthritis of the Hip Is Reversible After Arthroplasty A Longitudinal Voxel-Based Morphometric Study

TL;DR: The findings confirm that gray matter volume decreases within the left thalamus in the presence of chronic pain and disability in patients with hip OA and show that these thalamic volume changes reverse after hip arthroplasty and are associated with decreased pain and increased function.
Journal ArticleDOI

Evidence that central sensitisation is present in patients with shoulder impingement syndrome and influences the outcome after surgery

TL;DR: If patients with shoulder pain associated with impingement had relatively high levels of central sensitisation pre-operatively, as indicated by higher levels of punctate hyperalgesia and/or referred pain, the outcome three months after subacromial decompression was significantly worse.
Journal ArticleDOI

Chronic inflammation is a feature of Achilles tendinopathy and rupture.

TL;DR: Tissue and cells derived from tendinopathic and ruptured Achilles tendons show evidence of chronic (non-resolving) inflammation and strategies that target chronic inflammation are of potential therapeutic benefit for patients with Achilles tendon disease.